title: Characterization of the m4 muscarinic receptor Ca2+ response in a subclone of PC-12 cells by single cell flow cytometry. Inhibition of the response by bradykinin.
abstract: We have studied Ca2+ mobilization mediated by the constitutively expressed muscarinic receptor on a subclone of PC-12 cells. The subclone, ACH2, was isolated with a flow cytometer by selection of single cells that exhibited a strong intracellular Ca2+ response to acetylcholine (ACh). Cell to cell heterogeneity of resting Ca2+ levels was markedly reduced in the subclone and homogeneity of the population response was also dramatically improved. ACH2 cells were highly sensitive to ACh and the Ca2+ response in all cells was blocked by muscarinic antagonists. Membranes from ACH2 exhibited muscarinic binding affinities which were not typical of M1, M2, or M3 receptors but were consistent with the profile of the putative m4 receptor. The same percentage of cells responded to ACh whether or not extracellular Ca2+ was reduced with EGTA, but the response was eliminated in all cells by preincubation with pertussis toxin. Thus, the constitutive m4 receptor on ACH2 cells is efficiently coupled to intracellular Ca2+ release by a pertussis toxin-sensitive mechanism. Stimulation of the ACH2 cells by bradykinin (BK) evoked a Ca2+ response in 90% of the cells. Prestimulation with BK diminished the magnitude of the muscarinic Ca2+ response but did not reduce the number of cells which responded to ACh. Inhibition was partially attributed to inhibition of a Ca2+ influx pathway in resting cells. Thus, the signaling mechanism coupled to the m4 muscarinic receptor can be inhibited by signals initiated by the BK receptor.
authors.affiliation: Department of Molecular Immunology, Syntex Research, Palo Alto, California 94304.
authors.forename: J T
authors.initials: JT
authors.lastname: Ransom
authors.forename: H M
authors.initials: HM
authors.lastname: Cherwinski
authors.forename: R E
authors.initials: RE
authors.lastname: Delmendo
authors.forename: N A
authors.initials: NA
authors.lastname: Sharif
authors.forename: R
authors.initials: R
authors.lastname: Eglen
mesh_terms: D000110:Acetylcholinesterase / Q000378:metabolism; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001920:Bradykinin / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D005434:Flow Cytometry; D018727:Muscarinic Antagonists; D037342:Pertussis Toxin; D010890:Pirenzepine / Q000494:pharmacology; D051381:Rats; D011976:Receptors, Muscarinic / Q000378:metabolism*; D013379:Substrate Specificity; D014407:Tumor Cells, Cultured; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
chemical_list: D002800:Cholinesterase Inhibitors; D018727:Muscarinic Antagonists; D011976:Receptors, Muscarinic; D010566:Virulence Factors, Bordetella; D010890:Pirenzepine; D001285:Atropine; D037342:Pertussis Toxin; D000110:Acetylcholinesterase; D001920:Bradykinin; D002118:Calcium